Committed to bringing more of our medicines to more people, no matter where they are, while following high ethical standards.

We are improving access to healthcare through extensive investments in data science and technology, increasing our efficiency, supporting innovation, and thus better responding to the needs of patients and physicians.

Through our core business – the discovery, development and marketing of innovative treatments – we have helped prevent and treat diseases, ease suffering and improve quality of life for people worldwide.

But as the size and complexity of the world’s healthcare challenges grow, we must widen our scope, extending our impact even further by asking: How can we effectively address the needs of underserved populations? How can we bring the benefits of our medicines to more people? And how can we do this in a way that is sustainable for our business?

It begins with a fundamental shift in the way we do business – with reimagining new ways to bridge the divide between those with access to critical healthcare innovations and those without.

Novartis Access Principles

Our Access Principles include affordability strategies, research and development based on society’s healthcare needs and strengthening healthcare systems.